COVID-19 in Hospitalized Adults With HIV

Kate Stoeckle1,2, Carrie D Johnston1,3,2, Deanna P Jannat-Khah1,4

  • 1Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Insights

COVID-19 outcomes in people with HIV (PWH) were similar to those without HIV. PWH were hospitalized with less severe hypoxemia, a finding needing further study.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • The COVID-19 pandemic caused global morbidity and mortality.
  • Clinical outcomes for SARS-CoV-2 and HIV co-infection were unclear.

Purpose of the Study:

  • To compare clinical characteristics and outcomes of COVID-19 in hospitalized patients with and without HIV co-infection.

Main Methods:

  • Retrospective cohort study of 30 people with HIV (PWH) and 90 controls hospitalized with COVID-19 in NYC.
  • Matched analysis based on age, sex, and race/ethnicity.
  • Compared demographics, clinical features, and outcomes using electronic health records.

Main Results:

  • No significant differences in symptoms, disease duration, lab markers, or chest x-ray findings.
  • Patients without HIV required more supplemental oxygen upon presentation.
  • No differences in mechanical ventilation, hospital stay duration, or in-hospital mortality.

Conclusions:

  • COVID-19 clinical manifestations and outcomes were similar between PWH and controls.
  • PWH presented with less severe hypoxemia, requiring further investigation.
Abstract

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
696
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
625
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
675
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
637
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K